FCI
BIO icon

Financial Counselors Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Financial Counselors Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-798
Closed -$280K – 520
2020
Q1 		$280K Sell
798
-210
-21% -$77.2K 0.01% 372
2019
Q4 		$373K Buy
1,008
+20
+2% +$7.05K 0.01% 381
2019
Q3 		$329K Buy
988
+14
+1% +$4.57K 0.01% 395
2019
Q2 		$304K Sell
974
-245
-20% -$73.4K 0.01% 397
2019
Q1 		$373K Buy
+1,219
New +$329K 0.02% 364

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Financial Counselors Inc's BIO Position: Q2 2020 in Review

Financial Counselors Inc sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 798 shares — an estimated $280K sold.

Financial Counselors Inc first reported a position in BIO in Q1 2019 and held it in 5 quarters. The position peaked at $373K in Q4 2019. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Financial Counselors Inc reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Financial Counselors Inc sold 798 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $280K.
  • Financial Counselors Inc first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 5 quarters.
  • Financial Counselors Inc's Bio-Rad Laboratories Class A position peaked at $373K in Q4 2019.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Financial Counselors Inc's 13F filing for Q2 2020, filed 7 Aug 2020.